Poland· PL-100054091
Polcortolon
A triamcinolone product containing triamcinolonum, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Triamcinolone is registered in 14 of 19 countries.
Countries holding a registration under ATC H02AB08 (triamcinolone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Triamcinolone · ATC H02AB08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of triamcinolone costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Triamcinolone · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.42
The record
At a glance
URPL (Poland)- Active substance
- Triamcinolonum
- Manufacturer
- Adamed Pharma S.A.
- Country
- Poland (PL)
- ATC code
- H02AB08
- ATC class
- Triamcinolone
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990171316
- gtin05909990171323
- gtin05909990915446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
806 interactions on record for triamcinolone.
Graded by severity as the source publishes them — 84 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triamcinolone · interactions on record
806 records
- 84 severe
- 366 moderate
- 38 minor
- 298 info
Most severe, free to view
- LonafarnibA16AX20severe
- DesirudinB01AE01severe
- ConivaptanC03XA02severe
- Magnesium hydroxideA02AA04moderate
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triamcinolone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandKenacort
- FinlandLedercortWyeth Lederle Nordiska Ab
- NorwayVolonDermapharm
- United States24 Hour Nasal AllergyMeijer Distribution Inc
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Norway · Kenacort-T, Nasacort
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32d880e8-5be9-475e-996e-22684859f3a9 GET /v1/drugs/32d880e8-5be9-475e-996e-22684859f3a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "4 mg",
"packaging": "05909990171316 ¦ Rp ¦ 8110\n1 fiol. 20 tabl.\n05909990171323 ¦ Rp ¦ Skasowane ¦ 21439\n20 tabl. w blistrze\n05909990915446 ¦ Rp ¦ 70903\n20 tabl. w blistrze",
"substance": "Triamcinolonum 4 mg",
"common_name": "Triamcinolonum",
"pl_product_id": "100054091",
"pozwolenie_nr": "01713",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.